PlexBio Co., Ltd. (TPEX:6572)
7.65
-0.04 (-0.52%)
Aug 26, 2026, 1:42 PM CST
PlexBio Revenue
PlexBio had revenue of 68.82M TWD in the half year ending December 31, 2025, a decrease of -2.19%. This brings the company's revenue in the last twelve months to 137.57M, down -10.12% year-over-year. In the year 2025, PlexBio had annual revenue of 127.10M, down -0.76%.
Revenue (ttm)
137.57M
Revenue Growth
-10.12%
P/S Ratio
5.79
Revenue / Employee
n/a
Employees
n/a
Market Cap
797.06M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 127.10M | -967.00K | -0.76% |
| Dec 31, 2024 | 128.06M | -39.11M | -23.40% |
| Dec 31, 2023 | 167.18M | -24.01M | -12.56% |
| Dec 31, 2022 | 191.19M | 66.25M | 53.02% |
| Dec 31, 2021 | 124.94M | 23.60M | 23.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.78B |
| Cowealth Medical Holding | 2.86B |
| Bioptik Technology Incorporation | 912.86M |
| Diamond Biotechnology | 464.63M |
| Radiant Innovation | 409.16M |
| Health & Life | 400.09M |
| Wiltrom | 314.09M |
| S&S Healthcare Holding | 172.45M |